Giovanni Cazzaniga, Paola De Lorenzo, Julia Alten, Silja Röttgers, Jeremy Hancock, Vaskar Saha, Anders Castor, Hans O. Madsen, Virginie Gandemer, Hélène Cavé, Veronica Leoni, Rolf Köhler, Giulia M. Ferrari, Kirsten Bleckmann, Rob Pieters, Vincent van der Velden, Jan Stary, Jan Zuna, Gabriele Escherich, Udo zur Stadt, Maurizio Aricò, Valentino Conter, Martin Schrappe, Maria Grazia Valsecchi, and Andrea Biondi. 2017. “Predictive Value of Minimal Residual Disease in Philadelphia-Chromosome-Positive Acute Lymphoblastic Leukemia Treated With Imatinib in the European Intergroup Study of Post-Induction Treatment of Philadelphia-Chromosome-Positive Acute Lymphoblastic Leukemia, Based on immunoglobulin/T-Cell Receptor and BCR/ABL1 Methodologies”. Haematologica 103 (1). Pavia, Italy, 107-15. https://doi.org/10.3324/haematol.2017.176917.